Azenta, Inc. (Nasdaq: AZTA) Announces Completion of Corporate Name and Stock Ticker Symbol Change From Brooks Automation, Inc. (Nasdaq: BRKS)

Effective at the open of market trading today, the Company will begin trading as Azenta, Inc. (Nasdaq: AZTA) CHELMSFORD, Mass., Dec. 1, 2021 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or the “Company”) announced today that it has completed its previously announced corporate name change from “Brooks Automation, Inc.” to “Azenta, Inc.” In conjunction with the corporate name... Read more

Roche completes purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases

TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemic The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche’s LightCycler PCR instruments TIB Molbiol will continue to focus on the research and development... Read more

PacBio Names Jason Kang as Vice President and General Manager for Asia-Pacific Region

MENLO PARK, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing platforms, welcomes Jason Kang as Vice President and General Manager for the company’s Asia-Pacific region. Jason will be responsible for leading and developing PacBio’s commercial team in Asia-Pacific as the company continues to expand its reach in... Read more

New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genome Editing

New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genome Editing Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications CARLSBAD, Calif., Nov. 30, 2021 /PRNewswire/ — For research applications requiring highly precise genome editing, including engineering CAR T cells and creating cellular models for disease discovery, the Invitrogen... Read more

GE Healthcare Announces Three New Alliances to Help Improve Cancer Care

Collaborations with SOPHiA GENETICS, The University of Cambridge and Optellum are intended expand access to the latest and most advanced technologies for cancer care Chicago, Nov 30 2021 — GE Healthcare announced collaborations with SOPHiA GENETICS, The University of Cambridge and Optellum as part of its vision to advance care, make precision health more accessible,... Read more

PerkinElmer Confirms That Omicron Variant Does Not Impact SARS-CoV-2 Detection Capability of its RT-PCR Assays

Diagnostic accuracy of PerkinElmer’s COVID-19 PCR tests remains unaffected WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 29, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the performance of its SARS-CoV-2 RT-PCR assays are not impacted by the emergence of Omicron (B.1.1.529), a variant of concern that was recently identified... Read more

GE Healthcare Introduces An Industry-First Modular, Scalable CT Platform to Minimize Technology Obsolescence & Maximize Clinical Capabilities

GE Healthcare introduces the industry’s first[i] computed tomography (CT) platform with built-in scalability and upgradability[ii] The new Revolution Apex platform offers the world’s fastest gantry speed: 0.23 seconds per rotation and 19.5 millisecond effective temporal resolution to freeze cardiac motion[iii] Altogether, the company’s CT platform enables healthcare facilities to keep up with the latest technology... Read more

GE Healthcare Introduces An Industry-First Modular, Scalable CT Platform to Minimize Technology Obsolescence & Maximize Clinical Capabilities

GE Healthcare introduces the industry’s first[i] computed tomography (CT) platform with built-in scalability and upgradability[ii] The new Revolution Apex platform offers the world’s fastest gantry speed: 0.23 seconds per rotation and 19.5 millisecond effective temporal resolution to freeze cardiac motion[iii] Altogether, the company’s CT platform enables healthcare facilities to keep up with the latest technology... Read more

Cancer Patients may get Faster and more Personalized Treatment as result of Collaboration between GE Healthcare, University of Cambridge and Addenbrooke’s hospital

Teams plan to cooperate on the development of a machine learning-based solution, aiming to improve care for cancer patients by giving cancer care teams access to complex data and information The potentially transformative solution will initially focus on ovarian cancer and will then expand for use in breast and kidney cancer.  Cambridge/Chalfont St Giles, UK;... Read more